2020 was a challenging year for all investors, but the added operational strains from COVID-19 made it particularly difficult for healthcare systems.
The onset of the pandemic dramatically changed the healthcare landscape in a matter of weeks, resulting in industry-wide furloughs and reductions in capital expenditures. The postponement of elective procedures and other services to preserve personnel and resource capacity for COVID-19 cases placed enormous strain on the healthcare system. As a localized epidemic turned into a global pandemic, investment markets responded with steep declines and nationwide stay-at-home orders led to a collapse in economic activity and a spike in unemployment.
Fortunately, markets rebounded in record fashion. However, volatility is likely to persist in reaction to any advances or setbacks in the development and distribution of a vaccine. For investors, the pandemic has brought the return of a familiar foe — ultra-low interest rates, initially spurred by a flight-to-quality in bond markets and reinforced by a monetary pledge to do “whatever it takes.”
This paper aims to provide health systems with a practical, actionable checklist for the year ahead. We hope to offer some clarity on the question, “Where do we go from here?”
This paper focuses on these areas of consideration for 2021:
Download the whitepaper to learn more.